---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-173770"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:24:05.852071+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioMarin receives French FDI clearance for Amicus merger; closing expected April 27, 2026

## Summary
- French Ministry of Economics and Finance granted FDI clearance for merger with Amicus on April 23, 2026.
- Receipt of clearance satisfies final condition to the merger other than closing conditions.
- Merger expected to close on April 27, 2026.

## SEC filing metadata
- accession: 0001193125-26-173770
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/0001193125-26-173770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/d139584d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-173770
- JSON: https://secwatch.observer/filing/0001193125-26-173770.json
- Plain text: https://secwatch.observer/filing/0001193125-26-173770.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.